DHAC SEC-Einreichungen - Digital Health Acquisition Corp.- Jahresbericht, Proxy Statement, Prospekt

Basisstatistiken

CIK

1864531

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Digital Health Acquisition Corp.

SEC Filings (Chronological Order)

Auf dieser Seite finden Sie eine vollständige, chronologische Liste der SEC-Einreichungen, mit Ausnahme der Eigentumseinreichungen, die wir an anderer Stelle bereitstellen.

June 5, 2026	EX-10.1	STOCK PURCHASE AGREEMENT Exhibit 10.1 STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of May 31, 2026, by and between VSee Health, Inc., a Delaware corporation (“VSee Health”) and Milton Chen, an individual (“Chen” and, together with VSee Health, the “Parties” and, each individually, a “Party”). RECITALS WHEREAS, VSee Health owns one hundred percent (100%) of the equity securities (the
June 5, 2026	EX-99.1	VSEE HEALTH, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Exhibit 99.1 VSEE HEALTH, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS On May 31, 2026, VSee Health, Inc., a Delaware corporation (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Milton Chen, the Company’s co-Chief Executive Officer and Chairman of the Board and the Chief Executive Officer of VSee Lab, Inc., a Delaware Corporation and
June 5, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2026 (May 31, 2026) VSEE UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2026 (May 31, 2026) VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Comm
May 29, 2026	424B3	VSee Health, Inc. 3,000,000 Shares of Common Stock Up to 1,300,000 Shares of Common Stock Issuable Upon Exercise of the Series B Convertible Preferred Stock Up to 19,672,130 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 9,836,065 Sh Filed Pursuant to Rule 424(b)(3) Registration No. 333-292464 PROSPECTUS SUPPLEMENT NO. 2 (to prospectus dated January 7, 2026) VSee Health, Inc. 3,000,000 Shares of Common Stock Up to 1,300,000 Shares of Common Stock Issuable Upon Exercise of the Series B Convertible Preferred Stock Up to 19,672,130 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 9,836,065 Shares of Common Stock Is
May 15, 2026	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 ☐ TRANSITION REPORT P UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41015 VSee Heal
April 2, 2026	424B3	VSEE INC. 3,000,000 Shares of Common Stock Up to 1,300,000 Shares of Common Stock Issuable Upon Exercise of the Series B Convertible Preferred Stock Up to 19,672,130 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 9,836,065 Shares of Filed Pursuant to Rule 424(b)(3) Registration No. 333-292464 PROSPECTUS SUPPLEMENT NO. 2 (to prospectus dated January 7, 2026) VSEE INC. 3,000,000 Shares of Common Stock Up to 1,300,000 Shares of Common Stock Issuable Upon Exercise of the Series B Convertible Preferred Stock Up to 19,672,130 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 9,836,065 Shares of Common Stock Issuable U
April 2, 2026	POS EX	As filed with the Securities and Exchange Commission on April 1, 2026. As filed with the Securities and Exchange Commission on April 1, 2026. Registration No. 333-292464 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-effective Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 8000 86-2970927 (State or other jurisdiction of
March 31, 2026	EX-4.13	DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED Exhibit 4.13 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED VSee Health, Inc. (“us”, “our,” “we” or the “Company”) has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”): (i) our common stock, par value $0.0001 per share (“Common Stock”), and
March 31, 2026	EX-21.2	The list of Subsidiaries of VSee Health, Inc are as follows: Exhibit 21.2 The list of Subsidiaries of VSee Health, Inc are as follows: iDoc Virtual Telehealth Solutions, INC VSee Lab Inc.
March 31, 2026	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41015 VSee Health, I
March 5, 2026	424B3	VSEE INC. 3,000,000 Shares of Common Stock Up to 1,300,000 Shares of Common Stock Issuable Upon Exercise of the Series B Convertible Preferred Stock Up to 19,672,130 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 9,836,065 Shares of Filed Pursuant to Rule 424(b)(3) Registration No. 333-292464 PROSPECTUS SUPPLEMENT NO. 1 (to prospectus dated January 7, 2026) VSEE INC. 3,000,000 Shares of Common Stock Up to 1,300,000 Shares of Common Stock Issuable Upon Exercise of the Series B Convertible Preferred Stock Up to 19,672,130 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 9,836,065 Shares of Common Stock Issuable U
March 3, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2026 VSEE HEALTH, INC. ( UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2026 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File Nu
February 19, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 26, 2025 VSEE HEALTH, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 26, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
February 19, 2026	EX-10.2	STOCK PURCHASE AGREEMENT Exhibit 10.2 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (this “Agreement”) is entered into as of January 16, 2026 (the “Effective Date”) by and among Go My Rx, Inc., a Wyoming corporation (the “Company”), Go Biz Holdings, LLC, a Wyoming limited liability company (“Seller”) and each of the following purchasers listed on Exhibit A (each, a “Purchaser” and collectively, the “Purchasers”).
February 19, 2026	EX-10.1	MANAGED SERVICES AGREEMENT Exhibit 10.1 MANAGED SERVICES AGREEMENT This MANAGED SERVICES AGREEMENT (this “Agreement”), dated as of December 26, 2025, is made by and among GoMyRx (“Seller” or “GMRx”), and VSEE HEALTH Inc., a Florida corporation (“VSEE”) and iDoc Virtual Telehealth Solutions, Inc (iDoc) as “Buyer”. Each of Seller and VSEE and iDoc is sometimes referred to herein as a “Party” and together, as the “Parties”. Ca
February 17, 2026	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission
February 5, 2026	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
January 26, 2026	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
January 8, 2026	424B3	3,000,000 Shares of Common Stock Up to 1,300,000 Shares of Common Stock Issuable Upon Exercise of the Series B Convertible Preferred Stock Up to 19,672,130 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 9,836,065 Shares of Common Sto Filed Pursuant to Rule 424(b)(3) Registration No. 333-292464 PROSPECTUS 3,000,000 Shares of Common Stock Up to 1,300,000 Shares of Common Stock Issuable Upon Exercise of the Series B Convertible Preferred Stock Up to 19,672,130 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 9,836,065 Shares of Common Stock Issuable Upon Exercise of Pre-Funded Warrants VSee Health, Inc. This prospe
January 5, 2026	LETTER	LETTER January 5, 2026 Milton Chen Co-Chief Executive Officer VSee Health, Inc. 980 N Federal Hwy Suite 304 Boca Raton , FL 33432 Re: VSee Health, Inc. Registration Statement of Form S-1 Filed December 29, 2025 File No. 333-292464 Dear Milton Chen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acce
January 5, 2026	CORRESP	VSEE HEALTH, INC. January 5, 2026 VSEE HEALTH, INC. January 5, 2026 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Re: VSee Health, Inc. Registration Statement on Form S-1 Filed December 29, 2025 File No. 333-292464 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, VSee Health, Inc. (the
January 2, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2025 VSEE HEALTH, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
December 29, 2025	EX-10.67	AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT Exhibit 10.67 AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT This AMENDMENT NO.1, dated December 29, 2025 (this Amendment”), TO THE SECURITIES PURCHASE AGREEMENT, dated as of December 9, 2025 (the “Purchase Agreement”), by and between VSEE HEALTH, INC., a Delaware corporation (the “Company”) and MANATT, PHELPS & PHILLIPS, LLP, a California limited liability partnership (“Manatt”). WHEREAS: A. Th
December 29, 2025	S-1	As filed with the Securities and Exchange Commission on December 29, 2025. As filed with the Securities and Exchange Commission on December 29, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 8000 86-2970927 (State or other jurisdiction of incorporation or organization) (Prim
December 29, 2025	EX-FILING FEES	CALCULATION OF FILING FEE TABLES VSee Health, Inc. Table 1: Newly Registered and Carry Forward Securities Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-1 VSee Health, Inc. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Common Stock (1) Ot
December 29, 2025	EX-10.66	SECURITIES PURCHASE AGREEMENT Exhibit 10.66 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 9, 2025, is by and among VSee Health, Inc., a Delaware corporation (the “Company”), and Manatt, Phelps & Phillips, LLP (“Manatt”). The Company and Manatt are together the “Parties”. RECITALS A. The Company and Manatt are executing and delivering this Agreement in reliance upon the
December 18, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2025 VSEE HEALTH, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
December 18, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission
December 18, 2025	EX-3.1	AMENDMENT NO. 1 TO THE AMENDED AND RESTATED BYLAWS OF VSEE HEALTH, INC. (a Delaware corporation) Exhibit 3.1 AMENDMENT NO. 1 TO THE AMENDED AND RESTATED BYLAWS OF VSEE HEALTH, INC. (a Delaware corporation) This Amendment No. 1 to the Bylaws (the “Bylaws”) of VSEE Health, Inc., a Delaware corporation (the “Corporation”), is effective as of December 17, 2025. WHEREAS, the Board of Directors of the Corporation has approved by unanimous written consent the Amendment No. 1 to the Bylaws as set for
December 12, 2025	EX-99.1	VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025 Exhibit 99.1 VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025 SAN JOSE, CALIFORNIA / December 12, 2025 / VSee Health, Inc. (NASDAQ: VSEE) a leader in innovative telemedicine solutions, today announced that it anticipates that it will not have a sufficient number of shares of the Company’s common stock present in person or represented by proxy at th
December 12, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2025 VSEE HEALTH, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
December 11, 2025	EX-3.1	VSEE HEALTH, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS SERIES B CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151(g) OF THE DELAWARE GENERAL CORPORATION LAW Exhibit 3.1 VSEE HEALTH, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES B CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151(g) OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Imoigele Aisiku, does hereby certify that: 1. I am the Co-Chief Executive Officer of VSee Health, Inc., a Delaware corporation (the “Corporation”). 2. The Corporation is authorized
December 11, 2025	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2025 VSEE HEALTH, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission F
December 11, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2025 VSEE HEALTH, INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
December 11, 2025	EX-99.1	Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheet Exhibit 99.1 September 30, Convertible Debt Transactions Warrant Conversion Transaction Pipe Investment Transaction Pro Forma December 1, December 31, 2025 (A) (B) (C) 2025 2024 (Audited) ASSETS Current assets Cash 472,759 1,500,003 5,520,069 7,492,831 326,115 Accounts receivable, net of allowance for credit losses 2,578,490 2,578,490 1,716,370 Due from related party 284,614 284,614 531,656 Prepai
November 28, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2025 VSEE HEALTH, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
November 28, 2025	EX-99.1	EXHIBIT 99.1 Exhibit 99.1 December 31, December 31, 2025 2024 (Unaudited) ASSETS Current assets Cash 5,902,759 326,115 Accounts receivable, net of allowance for credit losses 3,728,490 1,716,370 Due from related party 284,614 531,656 Prepaids and other current assets 422,522 446,826 Total current assets $ 10,338,385 $ 3,020,967 Right-of-use assets, net 293,588 379,585 Intangible assets, net 8,785,006 10,995,00
November 26, 2025	EX-4.2	COMMON STOCK PURCHASE WARRANT VSEE HEALTH, INC. Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR
November 26, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2025 VSEE HEALTH, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
November 26, 2025	EX-10.1	SECURITIES PURCHASE AGREEMENT Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of November 25, 2025, between VSee Health, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHEREAS, subject to the terms and conditions se
November 26, 2025	EX-10.2	[signature page follows] Exhibit 10.2 November 25, 2025 VSee Health, Inc. 980 N Federal Hwy #304 Boca Raton, Florida 33432 Attention: Mr. Imoigele Aisiku, Co-Chief Executive Officer Dear Mr. Aisiku: This letter (the “Agreement”) constitutes the agreement between A.G.P./Alliance Global Partners (“A.G.P.” or the “Placement Agent”) and VSee Health, Inc., a Delaware corporation (the “Company”), that the Placement Agent shall
November 26, 2025	EX-4.1	Pre-Funded WARRANT To purchase Shares of Common Stock VSEE HEALTH, INC. Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR
November 24, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
November 20, 2025	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 FORM 10-Q/A (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 FORM 10-Q/A (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00
November 17, 2025	EX-10.2	SECURITY AGREEMENT Exhibit 10.2 SECURITY AGREEMENT This Security Agreement (this “Agreement”) is entered into as of October 29, 2025, by and between VSee Health, Inc., a Delaware corporation (the “Company”), in favor of M2B Funding Corp., a Florida corporation (the “Secured Party”). WHEREAS, in connection with the Convertible Note Purchase Agreement by and between the Company and the Secured Party dated the date her
November 17, 2025	EX-10.1	CONVERTIBLE NOTE PURCHASE AGREEMENT Exhibit 10.1 CONVERTIBLE NOTE PURCHASE AGREEMENT This Convertible Note Purchase Agreement (this “Agreement”) is dated as of October 29, 2025 and between M2B Funding Corp., a Florida corporation with its principal office located at 66 W. Flagler Street, Suite 900, #10189, Miami, Florida 33130 (on its own behalf or that of its designees, collectively, the “Purchaser”), and VSee Health, Inc., a Delaw
November 17, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2025 VSEE HEALTH, INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
November 17, 2025	EX-10.2	DIRECTED STOCK PURCHASE AGREEMENT Exhibit 10.2 DIRECTED STOCK PURCHASE AGREEMENT This Directed Stock Purchase Agreement (this “Agreement”) is dated as of November 13, 2025, by and between VSee Health, Inc., a Delaware corporation (together with its successors and, if permitted, assigns, the “Company”), and Ascent Partners Fund LLC, a Delaware limited liability company (together with its successors and assigns, including any other
November 17, 2025	EX-4.1	VSee Health, Inc. Secured Convertible Promissory Note Exhibit 4.1 THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABL
November 17, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2025 VSEE HEALTH, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
November 17, 2025	EX-10.1	EXCHANGE AGREEMENT Exhibit 10.1 EXCHANGE AGREEMENT This Exchange Agreement (this “Agreement”) is dated as of November 13, 2025, between VSee Health, Inc. (the “Company” or “VSEE”) and the holder identified on the signature page hereto (the “Holder”). WHEREAS, the Holder beneficially owns and holds a promissory note of the Company, issued on March 20, 2025, in the principal amount (including the original issue discou
November 14, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 ☐ TRANSITION REPO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41015 VSee
November 14, 2025	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
October 29, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2025 VSEE HEALTH, INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
October 29, 2025	EX-10.1	WARRANT EXCHANGE AGREEMENT Exhibit 10.1 WARRANT EXCHANGE AGREEMENT This Warrant Exchange Agreement (this “Agreement”) is made and entered into as of October 29, 2025 (the “Effective Date”), by and between VSee Health, Inc., a Delaware corporation (the “Company”), and Alta Partners, LLC (the “Holder”). The Company and the Holder may be referred to herein individually as a “Party” and collectively as the “Parties”. RECITALS W
October 28, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2025 VSEE HEALTH, INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
October 22, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2025 VSEE HEALTH, INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
October 22, 2025	EX-10.1	19505 Biscayne Blvd. ● Suite 2350 ● Aventura, FL 33180 ● [email protected] Exhibit 10.1 19505 Biscayne Blvd. ● Suite 2350 ● Aventura, FL 33180 ● [email protected] To: VSEE HEALTH, INC. Attention: Imoigele Aisiku Co-Chief Executive Officer ([email protected]) October 21, 2025 Re: Amendment No. 1 Dear Imoigele Aisiku, Reference is made to the Securities Purchase Agreement, dated as of September 30, 2024 (as modified to the date hereof, the “Purchase Agreement”;
October 20, 2025	EX-10.2	NOTE PURCHASE AGREEMENT Exhibit 10.2 NOTE PURCHASE AGREEMENT This Note Purchase Agreement (this “Agreement”) is dated as of October 20, 2025, by and among VSee Health, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each, an “Initial Purchaser” and, including their respective successors and permitted assigns, a “Purchaser”) and Ascent Partners Fund LLC, a Delawar
October 20, 2025	EX-4.1	SENIOR SECURED PROMISSORY NOTE DUE May 20, 2026 Exhibit 4.1 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES REGULATIONS AND, ACCORDINGLY, MAY NOT BE SOLD, OFFERED FOR SALE OR PLEDGED AS SECURITY IN THE ABSENCE OF SUCH REGISTRATION WITHOUT RELIANCE ON AN EXEMPTION UNDER THE SECURITIES ACT AND COMPLIANCE WITH APPLICABLE STATE SECURITIES REGULATIONS. THIS NOT
October 20, 2025	EX-10.1	19505 Biscayne Blvd. ● Suite 2350 ● Aventura, FL 33180 ● [email protected] Exhibit 10.1 19505 Biscayne Blvd. ● Suite 2350 ● Aventura, FL 33180 ● [email protected] To: VSEE HEALTH, INC. Attention: Imoigele Aisiku Co-Chief Executive Officer ([email protected]) October 20, 2025 Re: Amendment No. 2 to the Security Agreements and the Guaranties (“Amendment Agreement”) Dear Imoigele Aisiku: Reference is made to (1) the Note Purchase Agreement, dated as of October 2
October 20, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2025 VSEE HEALTH, INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
October 15, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PU UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41015 VSee Healt
October 15, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT P UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41015 VSee Heal
October 14, 2025	EX-16.1	October 13, 2025 Exhibit 16.1 October 13, 2025 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read the statements included under Item 4.01 of the Form 8-K dated October 13, 2025 to be filed by our former client VSee Health, Inc. We agree with the statements under Item 4.01 insofar as they relate to our Firm. We are not in a po
October 14, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2025 VSEE HEALTH, I UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fi
October 10, 2025	EX-10.2	NOTE PURCHASE AGREEMENT Exhibit 10.2 NOTE PURCHASE AGREEMENT This Note Purchase Agreement (this “Agreement”) is dated as of October 8, 2025, by and among VSee Health, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each, an “Initial Purchaser” and, including their respective successors and permitted assigns, a “Purchaser”) and Ascent Partners Fund LLC, a Delaware
October 10, 2025	EX-4.1	SENIOR SECURED PROMISSORY NOTE DUE May 8, 2026 Exhibit 4.1 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES REGULATIONS AND, ACCORDINGLY, MAY NOT BE SOLD, OFFERED FOR SALE OR PLEDGED AS SECURITY IN THE ABSENCE OF SUCH REGISTRATION WITHOUT RELIANCE ON AN EXEMPTION UNDER THE SECURITIES ACT AND COMPLIANCE WITH APPLICABLE STATE SECURITIES REGULATIONS. THIS NOT
October 10, 2025	EX-10.1	19505 Biscayne Blvd. ● Suite 2350 ● Aventura, FL 33180 ● [email protected] Exhibit 10.1 19505 Biscayne Blvd. ● Suite 2350 ● Aventura, FL 33180 ● [email protected] To: VSEE HEALTH, INC. Attention: Imoigele Aisiku Co-Chief Executive Officer ([email protected]) October 8, 2025 Re: Amendment No. 1 to the Security Agreements and the Guaranties (“Amendment Agreement”) Dear Imoigele Aisiku: Reference is made to (1) the Note Purchase Agreement, dated as of October 8,
October 10, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 9, 2025 VSEE HEALTH, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 9, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
September 29, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2025 VSEE HEALTH, I UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fi
September 5, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2025 VSEE HEALTH, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
August 29, 2025	EX-21.2	The list of Subsidiaries of VSee Health, Inc are as follows: Exhibit 21.2 The list of Subsidiaries of VSee Health, Inc are as follows: iDoc Virtual Telehealth Solutions, INC VSee Lab Inc.
August 29, 2025	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41
August 28, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2025 VSEE HEALTH, INC. ( UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File Nu
August 28, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-4101
August 22, 2025	EX-99.1	VSee Health Receives Expected Additional Notice of Deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q for fiscal 2025 Exhibit 99.1 VSee Health Receives Expected Additional Notice of Deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q for fiscal 2025 San Jose, CA – August 22, 2025 - VSee Health, Inc. (Nasdaq: VSEE) (the “Company”), today announced that it received an additional expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC
August 22, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2025 VSEE HEALTH, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
August 11, 2025	EX-99.1	VSee Health, Inc. Receives Nasdaq Delisting Determination and Plans to Request Reconsideration Exhibit 99.1 VSee Health, Inc. Receives Nasdaq Delisting Determination and Plans to Request Reconsideration San Jose, CA — August 8, 2025 — VSee Health, Inc. (Nasdaq: VSEE, VSEEW) (“VSee Health” or the “Company”) today announced that on August 5, 2025, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that Nasdaq has det
August 11, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2025 VSEE HEALTH, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File N
May 30, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2025 VSEE HEALTH, INC. (E UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File Num
May 8, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2025 VSEE HEALTH, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File N
April 1, 2025	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 001-41015 CUSIP NUMBER: 92919Y102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 21, 2025	EX-10.4	VSee Health, Inc. Secured Convertible Promissory Note Exhibit 10.4 THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILAB
March 21, 2025	EX-10.5	SECURITY AGREEMENT Exhibit 10.5 SECURITY AGREEMENT This Security Agreement (this “Agreement”) is entered into as of March 20, 2025, by and between VSee Health, Inc., a Delaware corporation (the “Company”), in favor of [] (the “Secured Party”). WHEREAS, in connection with the Convertible Note Purchase Agreement by and between the Company and the Secured Party dated the date hereof (the “Purchase Agreement”), the Comp
March 21, 2025	EX-10.6	Re: Amendment No. 1 Exhibit 10.6 To: VSEE HEALTH, INC. Attention: Imoigele Aisiku Co-Chief Executive Officer ([email protected]) March 20, 2025 Re: Amendment No. 1 Dear Imoigele Aisiku: Reference is made to the Equity Purchase Agreement, dated as of November 21, 2023 (as modified to the date hereof, the “Purchase Agreement”), by and between VSee Health, Inc. (formerly known as Digital Health Acquisition Corp.), a D
March 21, 2025	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File N
March 21, 2025	EX-10.3	CONVERTIBLE NOTE PURCHASE AGREEMENT Exhibit 10.3 CONVERTIBLE NOTE PURCHASE AGREEMENT This Convertible Note Purchase Agreement (this “Agreement”) is dated as of March 20, 2025 and between [] with its principal office located at [] (on its own behalf or that of its designees, collectively, the “Purchaser”), and VSee Health, Inc., a Delaware corporation with its principal office located at 980 N. Federal Hwy, #304, Boca Raton, Florida
March 21, 2025	EX-10.2	PROMISSORY NOTE DUE NOVEMBER 1, 2025 Exhibit 10.2 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES REGULATIONS AND, ACCORDINGLY, MAY NOT BE SOLD, OFFERED FOR SALE OR PLEDGED AS SECURITY IN THE ABSENCE OF SUCH REGISTRATION WITHOUT RELIANCE ON AN EXEMPTION UNDER THE SECURITIES ACT AND COMPLIANCE WITH APPLICABLE STATE SECURITIES REGULATIONS. THIS NO
March 21, 2025	EX-10.1	Re: Amendment No. 1 Exhibit 10.1 To: VSEE HEALTH, INC. Attention: Imoigele Aisiku Co-Chief Executive Officer ([email protected]) March 20, 2025 Re: Amendment No. 1 Dear Imoigele Aisiku: Reference is made to the Securities Purchase Agreement, dated as of September 30, 2024 (as modified to the date hereof, the “Purchase Agreement”), by and among VSee Health, Inc., a Delaware corporation (together with its successors
January 30, 2025	EX-99.1	VSee Health Announces $870K Contract with National Mental Health Services Company Exhibit 99.1 VSee Health Announces $870K Contract with National Mental Health Services Company SAN JOSE, Calif.-January 27, 2025-VSee Health, Inc. (Nasdaq: VSEE), a leader in comprehensive digital health services and customized telehealth workflow streams, announces a contract renewal of approximately $870K with a nationwide provider of mental and behavioral healthcare services. This renewal under
January 30, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
January 27, 2025	EX-99.1	VSee Health Announces $935K Contracts with Major Medical Device Manufacturers Exhibit 99.1 VSee Health Announces $935K Contracts with Major Medical Device Manufacturers SAN JOSE, Calif.- January 21, 2025 -VSee Health, Inc. (Nasdaq: VSEE), a leader in comprehensive digital health services and customized telehealth workflow streams, announces contracts with several medical technology solution companies totaling approximately $935,000. These initial contracts underscore potent
January 27, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 21, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
January 16, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
January 16, 2025	EX-99.1	VSee Health Secures Major Contract with Leading Florida Health System to Deliver Home Health and TeleNursing Driving Healthcare Innovation and Growth Across Hospitals and Communities Exhibit 99.1 VSee Health Secures Major Contract with Leading Florida Health System to Deliver Home Health and TeleNursing Driving Healthcare Innovation and Growth Across Hospitals and Communities SAN JOSE, Calif. - January 10, 2025 -VSee Health, Inc. (Nasdaq: VSEE), a leader in comprehensive digital health services and customized telehealth workflow streams, has been awarded a significant contract
January 16, 2025	EX-99.2	VSee Health Awarded Multi-Year, $6M First Year, Government Contract to Deliver Rapid Configurable Telehealth Exhibit 99.2 VSee Health Awarded Multi-Year, $6M First Year, Government Contract to Deliver Rapid Configurable Telehealth SAN JOSE, Calif- January 13, 2025 -VSee Health, Inc. (Nasdaq: VSEE), a leading provider of comprehensive digital health services and customized telehealth workflow streams, has been awarded a multi-year government contract with $6M allocated for the first year. Under the contra
December 23, 2024	EX-99.2	VSee Health Secures Teleradiology Contract with Leading Post-Acute Care Hospital System Exhibit 99.2 VSee Health Secures Teleradiology Contract with Leading Post-Acute Care Hospital System SAN JOSE, Calif- December 19, 2024 -VSee Health, Inc. (Nasdaq: VSEE), a leader in telehealth solutions, today announced the award of a teleradiology contract with one of the largest post-acute care hospital systems in the United States. This partnership, set to launch in Q1 of 2025, marks the lates
December 23, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
December 23, 2024	EX-99.1	VSee Health Awarded Teleradiology Services Agreement with Premier, Inc. Exhibit 99.1 VSee Health Awarded Teleradiology Services Agreement with Premier, Inc. SAN JOSE, Calif. - December 18, 2024 -VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, has been awarded a national group purchasing agreement for teleradiology services with Premier, Inc., a leading technology-enabled health
December 18, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
December 18, 2024	EX-99.1	VSee Health Announces Partnership with Tele911 to Create First Virtual Emergency Department Exhibit 99.1 VSee Health Announces Partnership with Tele911 to Create First Virtual Emergency Department Combining Telehealth Innovation with Emergency Care Solutions to Address ER Overcrowding and EMS Staffing Challenges SAN JOSE, Calif.- December 16, 2024 -VSee Health (Nasdaq: VSEE), a leader in digital healthcare transformation, announces its partnership with Tele911, the nation’s foremost ER d
December 11, 2024	EX-99.1	VSee Health Partners with AbundaBox to Launch AbundaLife™: Transforming Health Record Management for Families Nationwide Exhibit 99.1 VSee Health Partners with AbundaBox to Launch AbundaLife™: Transforming Health Record Management for Families Nationwide SAN JOSE, Calif. - December 6, 2024 - VSee Health, Inc. (Nasdaq: VSEE), a leader in telehealth solutions renowned for its scalable technology and deep clinical expertise, announced a strategic partnership with AbundaBox to launch AbundaLife™, a groundbreaking health
December 11, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
November 26, 2024	424B3	VSEE HEALTH, INC. Up to 4,495,119 Shares of Common Stock TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration No. 333-283115 PROSPECTUS VSEE HEALTH, INC. Up to 4,495,119 Shares of Common Stock This prospectus relates solely to the resale by the selling stockholders named in this prospectus (collectively, with any of such stockholder’s transferees, pledgees, assignees, distributees, donees or successors-in-interest, the “Selling Stockholder
November 26, 2024	CORRESP	VSEE HEALTH, INC. 980 N Federal Hwy #304 Boca Raton, FL 33432 VSEE HEALTH, INC. 980 N Federal Hwy #304 Boca Raton, FL 33432 November 26, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: VSEE HEALTH, INC. Registration Statement on Form S-1 (File No.333-283115) (the “Registration Statement”) Acceleration Request Ladies and Gentlemen: VSee Health, Inc. hereby requests that the eff
November 25, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
November 25, 2024	EX-99.1	VSee Health and The TeleDentists Bring the First Virtual Oral Health Compliance Services to PointClickCare Marketplace Exhibit 99.1 VSee Health and The TeleDentists Bring the First Virtual Oral Health Compliance Services to PointClickCare Marketplace SAN JOSE, Calif. - November 21, 2024 - VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams, and The TeleDentists, the first-to-market virtual dentistry solution, have partnered to be the first and only Poin
November 20, 2024	EX-99.1	VSee Health, Health Tech Without Borders, and iDocta Expand Clinton Global Initiative Telehealth Pilots in Conflict-affected Regions of Africa Exhibit 99.1 VSee Health, Health Tech Without Borders, and iDocta Expand Clinton Global Initiative Telehealth Pilots in Conflict-affected Regions of Africa SAN JOSE, Calif. - November 19, 2024 - VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive digital health services for the rapid and scalable development of secure, customized telehealth workflow streams; Health Tech Without Borders (
November 20, 2024	424B3	Prospectus Supplement No. 2 (to Prospectus dated July 26, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-280845 Prospectus Supplement No. 2 (to Prospectus dated July 26, 2024) This Prospectus Supplement No. 2 supplements and amends our prospectus dated July 26, 2024 (the “Initial Prospectus”) and prospectus supplement No.1 dated September 27, 2024 (the “Prospectus”). The Selling Stockholder identified beginning on page 114 of the Initial Prospec
November 20, 2024	424B3	Prospectus Supplement No. 1 (to Prospectus dated October 17, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-281319 Prospectus Supplement No. 1 (to Prospectus dated October 17, 2024) This Prospectus Supplement No. 1 supplements and amends our prospectus dated October 17, 2024 (the “Prospectus”). The Prospectus relates to the issuance by us of up to 11,500,000 shares of our common stock, $0.0001 par value per share (the “Common Stock”) that are issua
November 20, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2024 VSEE HEALTH, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
November 19, 2024	S-1/A	As filed with the U.S. Securities and Exchange Commission on November 19, 2024 Table of Contents As filed with the U.S. Securities and Exchange Commission on November 19, 2024 Registration No. 333-283115 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No.1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other j
November 18, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
November 18, 2024	EX-99.1	VSee Health Reports Third Quarter 2024 Revenue Up 131% Year-over-Year Exhibit 99.1 VSee Health Reports Third Quarter 2024 Revenue Up 131% Year-over-Year SAN JOSE, Calif. - November 15, 2024 - VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, today provided a business update and reported financial results for the three and nine months ended September 30, 2024. Financial & Busine
November 15, 2024	LETTER	LETTER November 15, 2024 Imoigele Aisiku Co-Chief Executive Officer VSee Health, Inc. 980 N Federal Hwy #304 Boca Raton, FL 33432 Re: VSee Health, Inc. Registration Statement on Form S-1 Filed November 12, 2024 File No. 333-283115 Dear Imoigele Aisiku: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for
November 14, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number:
November 14, 2024	SC 13G/A	VSEE / VSee Health, Inc. / Dominion Capital L.L.C. - SC 13G/A Passive Investment SC 13G/A 1 g084552sc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* VSee Health, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 92919Y102 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriat
November 14, 2024	SC 13G/A	VSEE / VSee Health, Inc. / Ayrton Capital LLC Passive Investment SC 13G/A 1 formsc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* VSEE HEALTH INC. (f/k/a DIGITAL HEALTH ACQUISITION CORP.) (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 92919Y102 (CUSIP Number) June 24, 2024 (Date of Event Which Requires Filing of this Statemen
November 12, 2024	EX-FILING FEES	SEC Filing Fee Table Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) VSEE HEALTH, INC.
November 12, 2024	S-1	As filed with the U.S. Securities and Exchange Commission on November 12, 2024 Table of Contents As filed with the U.S. Securities and Exchange Commission on November 12, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorpora
November 12, 2024	EX-4.4(A)	Warrant Amendment dated November 8, 2024 to the Warrant issued on September 30, 2024. Exhibit 4.4 (a) AMENDMENT TO WARRANT TO PURCHASE SHARES OF COMMON STOCK OF VSEE HEALTH, INC. This Amendment to Warrant to Purchase Shares of Common Stock (the “Amendment”) is entered into as of November 8, 2024 (the “Effective Date”) by and between [ ] (the “Holder”) and VSEE Health, Inc., a Delaware corporation (the “Company”), for the purpose of amending certain terms of that certain Warrant to
November 12, 2024	EX-10.48	Lock-Up Agreement entered with Quantum Assets SPV, LLC on November 8, 2024. Exhibit 10.48 LOCK-UP AGREEMENT November 8, 2024 VSee Health, Inc. 980 N Federal Hwy, Suite 304 Boca Raton, FL 33432 Ladies and Gentlemen: Reference is made to the Convertible Note Purchase Agreement (the “Purchase Agreement”) by and between VSee Health, Inc. (f.k.a. Digital Health Acquisition Corp.) (the “Company”) and Quantum Assets SPV, LLC (“Quantum”) on November 21, 2023 and the Registration
November 12, 2024	EX-10.47	Securities Purchase Agreement, dated as of November 8, 2024, by and between VSee Health, Inc. and SCS, LLC. Exhibit 10.47 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 8, 2024, is by and between VSee Health, Inc., a Delaware corporation (the “Company”), and SCS, LLC (“SCS”, together with the Company the “Parties”). RECITALS A.The Parties are executing and delivering this Agreement in reliance upon the exemption from securities registration affor
November 12, 2024	EX-4.2 (A)	Warrant Amendment dated November 8, 2024 to the Warrant issued on October 5, 2022. Exhibit 4.2 (a) AMENDMENT TO WARRANT TO PURCHASE SHARES OF COMMON STOCK OF VSEE HEALTH, INC. This Amendment to Warrant to Purchase Shares of Common Stock (the “Amendment”) is entered into as of November 8, 2024 (the “Effective Date”) by and between [ ] (the “Holder”) and VSEE Health, Inc. (formerly known as Digital Health Acquisition Corp.), a Delaware corporation (the “Company”), for the purpose
October 30, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
October 30, 2024	EX-99.1	VSee Health and BabyLiveAdvice Partner to Reduce Maternal Care Disparities Through Innovative Maternal Care Model Supported by Virtual Nursing Exhibit 99.1 VSee Health and BabyLiveAdvice Partner to Reduce Maternal Care Disparities Through Innovative Maternal Care Model Supported by Virtual Nursing VSee Health and BabyLiveAdvice partner to provide end-to-end virtual maternal care services that support hospitals and FQHCs in maternity deserts and increase women's access to obstetric care BOCA RATON, Fla. - October 29, 2024 - VSee Health, I
October 22, 2024	EX-99.1	VSee Health Expands its Telehealth Service Offering with New GLP-1 Program to Address Obesity and Chronic Disease Exhibit 99.1 VSee Health Expands its Telehealth Service Offering with New GLP-1 Program to Address Obesity and Chronic Disease BOCA RATON, Fla. - October 21, 2024 - VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, announces the launch of a specialized program designed to tackle obesity and associated health
October 22, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
October 17, 2024	EX-99.1	VSee Health, Kwajalein Atoll Government, US Coast Guard Cadets Launch Sea Ambulance Telehealth for Improved USA Veteran Access to Healthcare EX-99.1 2 tm2426433d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 VSee Health, Kwajalein Atoll Government, US Coast Guard Cadets Launch Sea Ambulance Telehealth for Improved USA Veteran Access to Healthcare BOCA RATON, Fla., October 16, 2024 – VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, in collaboration with th
October 17, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
October 17, 2024	424B3	VSEE HEALTH, INC. Up to 11,500,000 Shares of Common Stock Issuable Upon the Exercise of Public Warrants Up to 25,050,000 Shares of Common Stock 424B3 1 tm2419985-7424b3.htm 424B3 TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration No. 333-281319 PROSPECTUS VSEE HEALTH, INC. Up to 11,500,000 Shares of Common Stock Issuable Upon the Exercise of Public Warrants Up to 25,050,000 Shares of Common Stock This prospectus relates to the issuance by us of up to 11,500,000 shares of our common stock, $0.0001 par value per share (the “C
October 15, 2024	EX-10.39	Equity Purchase Agreement, dated as of November 21, 2023, by and between Digital Health Acquisition Corp., and an institutional and accredited investor (incorporated by reference to Exhibit 10.39 filed with the Form S-1/A filed by the Registrant on October 15, 2024). Exhibit 10.39 EQUITY PURCHASE AGREEMENT THIS EQUITY PURCHASE AGREEMENT (this “Agreement”) dated as of November 21, 2023 is made by and between DOMINION CAPITAL LLC., a Connecticut limited liability company (the “Investor”), and DIGITAL HEALTH ACQUISITION CORP., a Delaware corporation (the “Company”). WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, t
October 15, 2024	CORRESP	VSEE HEALTH, INC. 980 N Federal Hwy #304 Boca Raton, FL 33432 VSEE HEALTH, INC. 980 N Federal Hwy #304 Boca Raton, FL 33432 October 15, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: VSEE HEALTH, INC. Registration Statement on Form S-1 (File No.333-281319) (the “Registration Statement”) Acceleration Request Ladies and Gentlemen: VSee Health, Inc. hereby requests that the effe
October 15, 2024	EX-10.40	Equity Purchase Commitment Note dated July 2, 2024 by and between VSee Health, Inc. and an institutional and accredited investor (incorporated by reference to Exhibit 10.40 filed with the Form S-1/A filed by the Registrant on October 15, 2024). Exhibit 10.40 NONE OF THIS SECURITY OR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, NONE OF THEM MAY BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECT
October 15, 2024	S-1/A	As filed with the U.S. Securities and Exchange Commission on October 15, 2024 As filed with the U.S. Securities and Exchange Commission on October 15, 2024 Registration No. 333-281319 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No.2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of inco
October 11, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File
October 11, 2024	S-1/A	As filed with the U.S. Securities and Exchange Commission on October 11, 2024 Table of Contents As filed with the U.S. Securities and Exchange Commission on October 11, 2024 Registration No. 333-281319 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No.1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other ju
October 11, 2024	EX-99.1	VSee Health Co-CEO and STAR-TIDES Chair to Discuss Digital Health Transformation and Cybersecurity in Fireside Chat Pre-registration now open for STAR-TIDES and Silicon Valley Forum Fireside Chat on October 22, 2024 at 1:00 p.m. Pacific time Exhibit 99.1 VSee Health Co-CEO and STAR-TIDES Chair to Discuss Digital Health Transformation and Cybersecurity in Fireside Chat Pre-registration now open for STAR-TIDES and Silicon Valley Forum Fireside Chat on October 22, 2024 at 1:00 p.m. Pacific time BOCA RATON, Fla., October 08, 2024 - VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow st
October 11, 2024	EX-99.2	VSee Health Co-CEO Among Keynote Speakers at iA-MED 2024: Future of Artificial Intelligence Symposium for healthcare professionals assembles international experts to discuss digital health and AI applications to transform the practice of healthcare Exhibit 99.2 VSee Health Co-CEO Among Keynote Speakers at iA-MED 2024: Future of Artificial Intelligence Symposium for healthcare professionals assembles international experts to discuss digital health and AI applications to transform the practice of healthcare BOCA RATON, Fla., October 09, 2024 - VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize work
October 8, 2024	EX-99.2	Form of Stock Option Agreement Exhibit 99.2 VSEE HEALTH, INC. 2024 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT Optionholder:                                Grant Date:                                 Option Exercise Price per Share1: USD $                    Total Option Exercise Price: USD $                    Number of Shares of Common Stock (“Shares”)1:                                Expiration Date2:
October 8, 2024	S-8	As filed with the Securities and Exchange Commission on October 8, 2024 As filed with the Securities and Exchange Commission on October 8, 2024 Registration No.
October 8, 2024	EX-99.1	2024 VSee Health, Inc. Incentive Plan (incorporated by reference to Exhibit 99.1 filed with the Form S-8 filed by the Registrant on October 8, 2024). Exhibit 99.1 VSee Health, Inc. 2024 Equity Incentive Plan 1. Purpose; Eligibility. 1.1 General Purpose. This VSee Health, Inc. 2024 Equity Incentive Plan (the “Plan”) is intended to enable VSee Health, Inc., a Delaware corporation (the “Company”) and its subsidiaries, VSee Lab, Inc., a Delaware corporation (“VSee”) and iDoc Telehealth Solutions, Inc., a Texas corporation (“iDoc” and together with
October 8, 2024	EX-99.4	Form of Restricted Stock Award Agreement Exhibit 99.4 VSEE HEALTH, INC. 2024 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT VSee Health, Inc., a Delaware corporation (“Company”), hereby grants an Award of Restricted Stock, subject to the terms, conditions, and restrictions of the Company’s 2024 Equity Incentive Plan (the “Plan”), and this Restricted Stock Award Agreement, including Appendix A attached hereto (the Restricted Stock
October 8, 2024	EX-99.3	Form of Restricted Stock Unit Agreement Exhibit 99.3 VSEE HEALTH, INC. 2024 EQUITY INCENTIVE PLAN RESTRICTED SHARE UNIT AWARD AGREEMENT VSee Health, Inc., a Delaware corporation (“Company”), hereby grants an Award of Restricted Share Units, subject to the terms, conditions, and restrictions of the Company’s 2024 Equity Incentive Plan (the “Plan”), and this Restricted Share Unit Award Agreement, including Appendix A attached hereto (the
October 8, 2024	EX-FILING FEES	Calculation of Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Form S-8 CaliberCos Inc. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule(1) Amount to be Registered(2) Proposed Maximum Offering Price per Share(1) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.0001 per share Other 2,544,021 $ 1.33 $ 3,383,547.93 $ 0.000
October 1, 2024	EX-10.7	Form of Lock-Up Agreement entered with directors and officers of VSee Health, Inc. on September 30, 2024 (incorporated by reference to Exhibit 10.7 filed with the Form 8-K filed by the Registrant on October 1, 2024). Exhibit 10.7 Lock-up Agreement [INVESTOR AND COLLATERAL AGENT] [ADDRESS] As of September 30, 2024 Ladies and Gentlemen: The undersigned understands that VSee Health, Inc., a Delaware corporation (together with its successors and, if permitted, assigns, the “Company”) intends to enter into a Securities Purchase Agreement (as modified from time to time, the “Purchase Agreement”) dated as of the date
October 1, 2024	EX-10.2	Senior Secured Convertible Promissory Note dated as of September 30, 2024 by and between VSee Health, Inc. and the investor therein (incorporated by reference to Exhibit 10.2 filed with the Form 8-K filed by the Registrant on October 1, 2024). Exhibit 10.2 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES REGULATIONS AND, ACCORDINGLY, MAY NOT BE SOLD, OFFERED FOR SALE OR PLEDGED AS SECURITY IN THE ABSENCE OF SUCH REGISTRATION WITHOUT RELIANCE ON AN EXEMPTION UNDER THE SECURITIES ACT AND COMPLIANCE WITH APPLICABLE STATE SECURITIES REGULATIONS. THIS NO
October 1, 2024	EX-10.3	Warrant, dated as of September 30, 2024 in favor the investor named therein (incorporated by reference to Exhibit 10.3 filed with the Form 8-K filed by the Registrant on October 1, 2024). Exhibit 10.3 WARRANT NO. 1 Date: September 30, 2024 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES REGULATIONS AND, ACCORDINGLY, MAY NOT BE SOLD, OFFERED FOR SALE OR PLEDGED AS SECURITY IN THE ABSENCE OF SUCH REGISTRATION WITHOUT RELIANCE ON AN EXEMPTION UNDER THE SECURITIES ACT AND COMPLIANCE WITH APPLICABLE
October 1, 2024	EX-10.5	Form of Security Agreement, dated September 30, 2024 Exhibit 10.5 security agreement This Security Agreement (this “Agreement”), dated as of September 30, 2024, is entered into by and among VSee Health, Inc. (the “Company”) and each of the other entities listed on the signature pages hereof or that becomes a party hereto pursuant to Section 7.6 (together with the Company, the “Grantors”) in favor of [COLLATERAL AGENT], a Delaware limited liability c
October 1, 2024	EX-10.6	Form of Guaranty, dated September 30, 2024 Exhibit 10.6 GUARANTY This Guaranty (this “Guaranty”), dated as of September 30, 2024, by and among VSee Lab, Inc., (“VSee Lab”), a Delaware corporation and a wholly owned subsidiary of VSee Health, Inc., a Delaware corporation (“VSee Health”), iDoc Virtual Telehealth Solutions, Inc. (“iDoc”), a Texas corporation and a wholly owned subsidiary of VSee Health, (together with VSee Lab and their succe
October 1, 2024	EX-10.1	Securities Purchase Agreement, dated as of September 30, 2024, by between VSee Health, Inc., and the investor therein (incorporated by reference to Exhibit 10.1 filed with the Form 8-K filed by the Registrant on October 1, 2024). Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of September 30, 2024, by and among VSee Health, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each, an “Initial Purchaser” and, including their respective successors and permitted assigns, a “Purchaser”) and [PURCHASER AND COLLAT
October 1, 2024	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fi
October 1, 2024	EX-10.4	Registration Rights Agreement dated as of September 30, 2024 by and between VSee Health, Inc. and the investor thereof (incorporated by reference to Exhibit 10.4 filed with the Form 8-K filed by the Registrant on October 1, 2024). Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”), dated as of September 30, 2024, is entered into by and among VSee Health, Inc., a Delaware corporation (together with its successors and, if permitted, assigns, the “Company”), and the holders identified on the signature pages hereto (each, together with its successors and, if permitted, assigns, a “H
September 27, 2024	424B3	Prospectus Supplement No. 1 (to Prospectus dated July 26, 2024) Filed Pursuant to Rule 424(b)(3) Registration No. 333-280845 Prospectus Supplement No. 1 (to Prospectus dated July 26, 2024) This Prospectus Supplement No. 1 supplements and amends our prospectus dated July 26, 2024 (the “Prospectus”). The Selling Stockholder identified beginning on page 114 of the Prospectus is offering on a resale basis a total of up to 2,310,545 shares of the Company’s common
September 23, 2024	EX-99.1	VSee Health Provides a Business Update and Reports Second Quarter 2024 Financial Results Exhibit 99.1 VSee Health Provides a Business Update and Reports Second Quarter 2024 Financial Results BOCA RATON, Fla., September 23, 2024 – VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, today provided a business update and reported financial results for the three and six months ended June 30, 2024. Busin
September 23, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-
September 23, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fi
September 11, 2024	EX-99.1	VSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing Exhibit 99.1 VSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing BOCA RATON, Fla., September 11, 2024 – VSee Health, Inc. (the “Company”) (Nasdaq: VSEE), announced today that on September 6, 2024, the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the quarterly pe
September 11, 2024	8-K	Regulation FD Disclosure, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission Fil
August 14, 2024	LETTER	LETTER August 14, 2024 Imoigele Aisiku Co-Chief Executive Officer VSEE HEALTH, INC. 980 N Federal Hwy #304 Boca Raton, FL 33432 Re: VSEE HEALTH, INC. Registration Statement on Form S-1 Filed August 7, 2024 File No. 333-281319 Dear Imoigele Aisiku: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for accel
August 14, 2024	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 001-41015 CUSIP NUMBER: 92919Y102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
August 8, 2024	EX-99.1	VSee Health and Stand Together Partner to Launch Aimee Telehealth Service Exhibit 99.1 VSee Health and Stand Together Partner to Launch Aimee Telehealth Service SAN JOSE, Calif., August 6, 2024 - VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, announced today the launch of its Aimee telehealth service in Wichita, Kansas, in partnership with Stand Together. Aimee is an innovative
August 8, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File N
August 7, 2024	EX-FILING FEES	SEC Filing Fee Table Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) VSEE HEALTH, INC.
August 7, 2024	S-1	As filed with the U.S. Securities and Exchange Commission on August 6, 2024 Table of Contents As filed with the U.S. Securities and Exchange Commission on August 6, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporatio
August 2, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File N
August 2, 2024	EX-99.1	VSee Health and Ava Robotics Partner to Develop Telepresence Solutions for the Hospital Inpatient Intensive Care Market Exhibit 99.1 VSee Health and Ava Robotics Partner to Develop Telepresence Solutions for the Hospital Inpatient Intensive Care Market SAN JOSE, Calif., August 1, 2024 – VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, and Ava Robotics, a developer of intelligent robots for the workplace, today announced an ag
July 29, 2024	EX-99.1	VSee Health to Provide Telehealth and Billing Services to SkywardRx Clients Exhibit 99.1 VSee Health to Provide Telehealth and Billing Services to SkywardRx Clients SAN JOSE, Calif., July 24, 2024 - VSee Health, Inc. (NASDAQ: VSEE), a provider of comprehensive telehealth services that customize telehealth workflow streams, enhance patient care and turnkey billing services, announces it has partnered with SkywardRx, a digital healthcare services and consulting firm, to pro
July 29, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File Nu
July 26, 2024	424B3	VSEE HEALTH, INC. Up to 2,310,545 Shares of Common Stock TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration No. 333-280845 VSEE HEALTH, INC. Up to 2,310,545 Shares of Common Stock This prospectus relates solely to the resale by the Selling Stockholder named in this prospectus (collectively, with any of such stockholder’s transferees, pledgees, assignees, distributees, donees or successors-in-interest, the “Selling Stockholder”) of up to 2
July 24, 2024	LETTER	LETTER July 24, 2024 Imoigele Aisiku Co-Chief Executive Officer VSee Health, Inc. 980 N Federal Hwy #304 Boca Raton, FL 33432 Re: VSee Health, Inc. Registration Statement on Form S-1 Filed July 17, 2024 File No. 333-280845 Dear Imoigele Aisiku: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for accelera
July 24, 2024	CORRESP	VSEE HEALTH, INC. 980 N Federal Hwy #304 Boca Raton, FL 33432 VSEE HEALTH, INC. 980 N Federal Hwy #304 Boca Raton, FL 33432 July 24, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: VSEE HEALTH, INC. Registration Statement on Form S-1 (File No.333-280845) (the “Registration Statement”) Acceleration Request Ladies and Gentlemen: VSee Health, Inc. hereby requests that the effecti
July 23, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File Nu
July 17, 2024	EX-FILING FEES	SEC Filing Fee Table Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) VSEE HEALTH, INC.
July 17, 2024	S-1	As filed with the U.S. Securities and Exchange Commission on July 17, 2024 Table of Contents As filed with the U.S. Securities and Exchange Commission on July 17, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation
July 15, 2024	EX-99.1	VSee Health Now Providing Outpatient Telehealth Services to the Federal Bureau of Prisons Company contract with Seven Corners Correctional Health, the operator of 24 federal prisons, allows it to offer inmates accessible, quality specialty care Exhibit 99.1 VSee Health Now Providing Outpatient Telehealth Services to the Federal Bureau of Prisons Company contract with Seven Corners Correctional Health, the operator of 24 federal prisons, allows it to offer inmates accessible, quality specialty care SAN JOSE, Calif., July 09, 2024 - VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow st
July 15, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2024 VSEE HEALTH, INC. (E UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File Num
July 9, 2024	8-K	Amendment to Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File Num
July 9, 2024	EX-10.2	Equity Purchase Commitment Note dated July 2, 2024 by and between VSee Health, Inc. and an institutional and accredited investor (incorporated by reference to Exhibit 10.2 filed with the Form 8-K filed by the Registrant on July 9, 2024). Exhibit 10.2 NONE OF THIS SECURITY OR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, NONE OF THEM MAY BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTI
July 9, 2024	EX-10.1	Amendment to Quantum Note dated as of July 3, 2024 by and between VSee Health, Inc. and the Quantum Investor (incorporated by reference to Exhibit 10.1 filed with the Form 8-K filed by the Registrant on July 9, 2024). Exhibit 10.1 AMENDMENT TO CONVERTIBLE PROMISSORY NOTE THIS AMENDMENT TO CONVERTIBLE PROMISSORY NOTE, dated as of July 3, 2024 (the "Amendment"), is entered into by VSee Health, Inc. (f/k/a Digital Health Acquisition Corp.), a Delaware corporation (“Borrower”) in favor of Quantum Assets SPV LLC, a Florida limited liability company (“Lender”). Borrower and Lender are referred to herein collectively
July 9, 2024	EX-14.1	Code of Ethics and Conduct of VSee Health, Inc. Exhibit 14.1 CODE OF ETHICS AND CONDUCT OF VSEE HEALTH, INC. 1. Introduction. 1.1            The Board of Directors of VSee Health, Inc. (together with its subsidiaries, the “Company”) has adopted this Code of Ethics and Conduct (the “Code”) in order to:   (a)            promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest;   (b)
July 5, 2024	SC 13G	US2538931195 / Digital Health Acquisition Corp. / Dominion Capital L.L.C. - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* VSee Health, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 92919Y102 (CUSIP Number) June 24, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which
July 1, 2024	SC 13D	US2538931195 / Digital Health Acquisition Corp. / CHEN MILTON - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* VSEE HEALTH, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 92919Y102 (CUSIP Number) Milton Chen, Co-Chief Executive Officer VSEE HEALTH, INC. 980 N. Federal Highway, #304 Boca Raton, FL 33432 561 672 7068 (
July 1, 2024	SC 13D	US2538931195 / Digital Health Acquisition Corp. / Sands Lawrence M. - SC 13D Activist Investment SC 13D 1 tm2418672d1sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* VSEE HEALTH, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 92919Y102 (CUSIP Number) Lawrence Sands c/o VSEE HEALTH, INC. 980 N. Federal Highway, #304 Boca Raton, FL 3343
July 1, 2024	SC 13D	US2538931195 / Digital Health Acquisition Corp. / Aisiku Imoigele - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* VSEE HEALTH, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 92919Y102 (CUSIP Number) Imoigele P. Aisiku, Co-Chief Executive Officer VSEE HEALTH, INC. 980 N. Federal Highway, #304 Boca Raton, FL 33432 561 672
June 28, 2024	EX-10.6	Quantum Registration Rights Agreement dated as of June 25, 2024 by and between VSee Health, Inc. and the Quantum Investor (incorporated by reference to Exhibit 10.6 filed with the Form 8-K filed by the Registrant on June 28, 2024). Exhibit 10.6 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) dated as of June 25, 2024 is made by and between QUANTUM ASSETS SPV LLC, a Florida limited liability company (the “Investor”), and DIGITAL HEALTH ACQUISITION CORP., a company incorporated under the laws of the state of Delaware (the “Company”). For purposes of this Agreement, references to the “Company
June 28, 2024	EX-16.1	Letter from Accell Audit & Compliance, PA dated June 28, 2024 to the Securities and Exchange Commission (incorporated by reference to Exhibit 16.1 filed with the Form 8-K filed by the Registrant on June 28, 2024) Exhibit 16.1 June 28, 2024 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by VSee Health, Inc. (formerly known as Digital Health Acquisition Corp.) under Item 4.01 of its Form 8-K dated June 28, 2024. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other
June 28, 2024	EX-99.2	iDoc Virtual Telehealth Solutions, INC. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the Three Months Ended March 31, 2024 and 2023 IDOC VIRTUAL TELEHEALTH SOLUTIONS, INC. FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023 INDEX TO UNAUD Exhibit 99.2 iDoc Virtual Telehealth Solutions, INC. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the Three Months Ended March 31, 2024 and 2023 IDOC VIRTUAL TELEHEALTH SOLUTIONS, INC. FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023 INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets at Mar
June 28, 2024	8-K	Regulation FD Disclosure, Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2024 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File Nu
June 28, 2024	EX-10.2	Exchange Registration Rights Agreement dated as of June 24, 2024 by and between VSee Health, Inc. and the Bridge Investor (incorporated by reference to Exhibit 10.2 filed with the Form 8-K filed by the Registrant on June 28, 2024).   Exhibit 10.2   REGISTRATION RIGHTS AGREEMENT   This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 24, 2024, by and among by VSee Health, Inc. (formerly known as Digital Health Acquisition Corp.), a Delaware Corporation (together with its successors and permitted assigns, the “Company”) and the holders identified on the signature pages hereto (each a “Purcha
June 28, 2024	EX-10.1	Exchange Note dated as of June 24, 2024 by and between VSee Health, Inc. and the Bridge Investor (incorporated by reference to Exhibit 10.1 filed with the Form 8-K filed by the Registrant on June 28, 2024). Exhibit 10.1 NONE OF THIS SECURITY OR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, NONE OF THEM MAY BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTI
June 28, 2024	EX-10.5	Quantum Note dated as of June 25, 2024 by and between VSee Health, Inc. and the Quantum Investor (incorporated by reference to Exhibit 10.5 filed with the Form 8-K filed by the Registrant on June 28, 2024). Exhibit 10.5 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSU
June 28, 2024	EX-99.5	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF IDOC Exhibit 99.5 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF IDOC The following discussion and analysis provide information that iDoc’s management believes is relevant to an assessment and understanding of the results of operations and financial condition of iDoc Virtual Telehealth Solutions, Inc. (“iDoc”) (for purposes of this section, collectively referre
June 28, 2024	EX-10.3	Form of Exchange Lock-Up Agreement entered with directors and officers of VSee Health, Inc. on June 24, 2024 (incorporated by reference to Exhibit 10.3 filed with the Form 8-K filed by the Registrant on June 28, 2024). Exhibit 10.3 VSEE HEALTH, INC. 980 N. Federal Hwy. #304 Boca Raton, FL 33432 LOCK-UP AGREEMENT June 24, 2024 Dominion Capital LLC 256 W 38th St 15th Floor New York, NY 10018 Re: Exchange Agreement, dated as of the date hereof, between VSee Health, Inc. f/k/a Digital Health Acquisition Corp., (the “Company”), VSee Lab, Inc. (“VSee”) and iDoc Virtual Telehealth Solutions, Inc. (“iDoc”) and each of t
June 28, 2024	EX-21.1	Subsidiaries of the Company. Exhibit 21.1 Subsidiaries of Registrant Name Percentage Ownership State or Country of Organization VSee Lab, Inc. 100% Delaware iDoc Virtual Telehealth Solutions, Inc. 100% Texas This American Doc, Inc. 100% Delaware iDoc Virtual Neuro Critical Care, LLC 100% Georgia iDoc Virtual Telehealth Texas, LLC 100% Texas iDoc Telehealth Solutions New Hampshire, LLC 100% New Hampshire Encompass Healthcare B
June 28, 2024	EX-10.7	Indemnification Agreements, dated June 24, 2024, by and between VSee Health, Inc. and each of the officers and directors (incorporated by reference to Exhibit 10.7 filed with the Form 8-K filed by the Registrant on June 28, 2024). Exhibit 10.7 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of June 24, 2024, by and between VSee Health, Inc. f/k/a Digital Health Acquisition Corp., a Delaware corporation (the “Company”), and (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless th
June 28, 2024	EX-99.1	VSee Lab, Inc. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the Three Months Ended March 31, 2024 and 2023 VSEE LAB, INC. FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023 INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Exhibit 99.1 VSee Lab, Inc. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the Three Months Ended March 31, 2024 and 2023 VSEE LAB, INC. FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023 INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Condensed Financial Statements Condensed Consolidated Balance Sheets at March 31, 2024 (Unaudited) and December 31, 2023 F-1 Condensed Con
June 28, 2024	EX-10.4	Amended and Restated Security Agreement dated June 24, 2024 by and among the Bridge Investor, VSee Health, Inc., VSee Lab, Inc., iDoc Virtual Telehealth Solutions, Inc. and grantors under the signature page thereof (incorporated by reference to Exhibit 10.4 filed with the Form 8-K filed by the Registrant on June 28, 2024). Exhibit 10.4 AMENDED AND RESTATED security agreement This Amended and Restated Security Agreement (this “Agreement”), dated as of June 24, 2024, is entered into by VSee Health, Inc. (formerly known as Digital Health Acquisition Corp.), a Delaware corporation (“VSEE”), VSee Lab, Inc., a Delaware corporation (“VSee Lab”) and iDoc Virtual Telehealth Solutions, Inc., a Texas corporation (“iDoc” and to
June 28, 2024	EX-99.4	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF VSEE Exhibit 99.4 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF VSEE The following discussion and analysis provide information that VSee’s management believes is relevant to an assessment and understanding of the results of operations and financial condition of VSee Lab, Inc. (“VSee” and for purposes of this section only, referred to as the “Company”, “we,” “u
June 28, 2024	EX-3.3	Amended and Restated Bylaws of VSee Health, Inc. (incorporated by reference to Exhibit 3.3 filed with the Form 8-K filed by the Registrant on June 28, 2024). Exhibit 3.3 Form of AMENDED AND RESTATED BYLAWS OF VSEE HEALTH, INC. Article I STOCKHOLDERS 1 1.1 Place of Meetings 1 1.2 Annual Meeting 1 1.3 Special Meetings 1 1.4 Notice of Meetings 1 1.5 Voting List 2 1.6 Quorum 2 1.7 Adjournments 2 1.8 Voting and Proxies 3 1.9 Action at Meeting 3 1.10 Nomination of Directors 3 1.11 Notice of Business to be Brought Before a Meeting 7 1.12 Conduct of Meetings 1
June 28, 2024	EX-3.2	Certificate of Designation of Series A Convertible Preferred Stock of VSee Health, Inc. (incorporated by reference to Exhibit 3.2 filed with the Form 8-K filed by the Registrant on June 28, 2024). Exhibit 3.2 Delaware Page 1 The First State I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF DESIGNATION OF “VSEE HEALTH, INC.”, FILED IN THIS OFFICE ON THE TWENTY-FOURTH DAY OF JUNE, A.D. 2024, AT 8:17 O’CLOCK A.M. /s/ Jeffrey W. Bullock Jeffrey W. Bullock, Secretary of State 5737553 8100 Authentica
June 28, 2024	EX-99.3	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Vsee Health, Inc ((formerly known as Digital Healthcare Acquisition Corp.) (“DHAC”)) (“VSee”, the “Company” or the “Combined Company”) is providing the following unaudited pro forma condensed combined financial information to aid you in your analysis of the financial aspects of the Business Combination and related transactio
June 28, 2024	EX-99.6	Digital Health Acquisition Corp. Announce Closing of Business Combination Transaction Company renamed VSee Health, Inc. Shares to trade on Nasdaq under the ticker “VSEE” on June 25, 2024 Exhibit 99.6 Digital Health Acquisition Corp. Announce Closing of Business Combination Transaction Company renamed VSee Health, Inc. Shares to trade on Nasdaq under the ticker “VSEE” on June 25, 2024 BOCA RATON, Fla., June 24, 2024 –Digital Health Acquisition Corp. (Nasdaq: DHAC), a Special Purpose Acquisition Company (SPAC), today announced the closing of its previously announced business combina
June 28, 2024	EX-3.1	Second Amended and Restated Certificate of Incorporation of VSee Health, Inc. (incorporated by reference to Exhibit 3.1 filed with the Form 8-K filed by the Registrant on June 28, 2024). Exhibit 3.1    Delaware Page 1 The First State     I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE RESTATED CERTIFICATE OF “DIGITAL HEALTH ACQUISITION CORP.”, CHANGING ITS NAME FROM “DIGITAL HEALTH ACQUISITION CORP.” TO “VSEE HEALTH, INC.”, FILED IN THIS OFFICE ON THE TWENTY-FOURTH DAY OF JUNE, A. D. 2024, AT 8:04
June 12, 2024	8-K	Other Events, Submission of Matters to a Vote of Security Holders United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 7, 2024 Date of Report (Date of earliest event reported) Digital Health Acquisition Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commi
May 15, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT T Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41015 DIG
May 13, 2024	424B3	PROPOSED MERGER YOUR VOTE IS VERY IMPORTANT TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration No. 333-268184 PROPOSED MERGER YOUR VOTE IS VERY IMPORTANT Dear Stockholders: You are cordially invited to attend the special meeting of the stockholders (the “Meeting”) of Digital Health Acquisition Corp. (“DHAC”), which will be held at 9:30 a.m., Eastern time, on June 7, 2024. The Board of Directors has determined to convene and c
May 10, 2024	CORRESP	DIGITAL HEALTH ACQUISITION CORP. 980 N Federal Hwy #304 Boca Raton, FL 33432 DIGITAL HEALTH ACQUISITION CORP. 980 N Federal Hwy #304 Boca Raton, FL 33432 May 10, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: Digital Health Acquisition Corp. Registration Statement on Form S-4, as amended (File No. 333-268184) (the “Registration Statement”) Acceleration Request Ladies and Gentlemen: Digital
May 9, 2024	CORRESP	Manatt, Phelps & Phillips, LLP 695 Town Center Drive, 14th Floor, Costa Mesa, California 92626 Tel: 714.371.2500 Fax: 714.371.2550 Albany \| Boston \| Chicago \| Los Angeles \| New York \| Orange County \| Sacramento \| San Francisco \| Silicon Valley \| Wash Thomas J. Poletti Manatt, Phelps & Phillips, LLP Direct Dial: (714) 371-2501 [email protected] May 9, 2024 Client-Matter: 65537-032 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Julie Sherman; Jeanne Baker; Juan Grana; Katherine Bagley Re: Digital Health Acquisition Corp. Amendment No. 8 to Registration Statemen
May 9, 2024	S-4/A	As filed with the Securities and Exchange Commission on May 8, 2024 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on May 8, 2024 Registration No.
May 8, 2024	CORRESP	Manatt, Phelps & Phillips, LLP 695 Town Center Drive, 14th Floor, Costa Mesa, California 92626 Tel: 714.371.2500 Fax: 714.371.2550 Albany \| Boston \| Chicago \| Los Angeles \| New York \| Orange County \| Sacramento \| San Francisco \| Silicon Valley \| Wash Thomas J. Poletti Manatt, Phelps & Phillips, LLP Direct Dial: (714) 371-2501 [email protected] May 8, 2024 Client-Matter: 65537-032 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Julie Sherman; Jeanne Baker; Juan Grana; Katherine Bagley Re: Digital Health Acquisition Corp. Amendment No. 6 to Registration Statemen
May 7, 2024	LETTER	LETTER United States securities and exchange commission logo May 7, 2024 Scott Wolf Chief Executive Officer Digital Health Acquisition Corp.
May 2, 2024	8-K	Other Events United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 1, 2024 Digital Health Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commi
April 24, 2024	EX-2.3	Second Amendment to the Third Amended and Restated Business Combination Agreement, dated as of April 17, 2024, by and among Digital Health Acquisition Corp., DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., and iDoc Virtual Telehealth Solutions, Inc. (included as Annex A to the proxy statement/prospectus/consent solicitation) Exhibit 2.3 DIGITAL HEALTH ACQUISITION CORP. Second AMENDMENT AND WAIVER This Second Amendment and Waiver (this “Second Amendment”) is made effective as of April 17, 2024 (the “Effective Date”), by and among Digital Health Acquisition Corp., a Delaware corporation (the “Company”), DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., and iDoc Virtual Telehealth Solutions, Inc. (each,
April 24, 2024	CORRESP	Manatt, Phelps & Phillips, LLP 695 Town Center Drive, 14th Floor, Costa Mesa, California 92626 Tel: 714.371.2500 Fax: 714.371.2550 Albany \| Boston \| Chicago \| Los Angeles \| New York \| Orange County \| Sacramento \| San Francisco \| Silicon Valley \| Wash Thomas J. Poletti Manatt, Phelps & Phillips, LLP Direct Dial: (714) 371-2501 [email protected] April 24, 2024 Client-Matter: 65537-032 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Julie Sherman; Jeanne Baker; Juan Grana; Katherine Bagley Re: Digital Health Acquisition Corp. Amendment No. 6 to Registration State
April 24, 2024	S-4/A	As filed with the Securities and Exchange Commission on April 24, 2024 Table of Contents As filed with the Securities and Exchange Commission on April 24, 2024 Registration No.
April 24, 2024	EX-10.20	Form of Escrow Agreement by and among VSee Health, Inc. (f/k/a Digital Health Acquisition Corp.), and each of VSee Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc, and Continental Stock Transfer & Trust Company, LLC. (incorporated by reference to Exhibit 10.20 filed with the Form S-4 filed by the Registrant on May 9, 2024) Exhibit 10.20 STOCK ESCROW AGREEMENT This STOCK ESCROW AGREEMENT (“Agreement”) is made and entered into as of [], 2024, by and among DIGITAL HEALTH ACQUISITION CORP., a Delaware corporation (“Parent”), VSEE LAB, INC., a Delaware Corporation (“VSee”), MILTON CHEN, an individual (the “VSee Company Representative”), IDOC VIRTUAL TELEHEALTH SOLUTIONS, INC., a Texas corporation, IMOIGELE AISIKU, an ind
April 18, 2024	EX-10.1	Letter Agreement dated April 17, 2024 to the Promissory Note dated November 21, 2023 and January 25, 2024 issued by Digital Health Acquisition Corp. to the Bridge Investor (incorporated by reference to Exhibit 10.1 filed with the Form 8-K filed by the Registrant on April 18, 2024). Exhibit 10.1 April 17, 2024 Re: Amendment to Notes Dear Sirs: Reference is made to (i) the Securities Purchase Agreement dated as of October 5, 2022 (as amended by the Letter Agreement dated as of November 21, 2023 and as further amended, superseded, replaced, or otherwise modified from time to time, the “Purchase Agreement”), between Digital Health Acquisition Corp., a Delaware corporation (the “
April 18, 2024	EX-10.2	Letter Agreement dated April 17, 2024 to the Extension Securities Purchase Agreement and Extension Note dated May 3, 2023 (incorporated by reference to Exhibit 10.2 filed with the Form 8-K filed by the Registrant on April 18, 2024). Exhibit 10.2 April 17, 2024 Re: Amendment to May 2023 Securities Purchase Agreement and Promissory Notes Dear Sir: Reference is made to (i) the Securities Purchase Agreement dated as of May 5, 2023 and as further amended, superseded, replaced, or otherwise modified from time to time, the “Purchase Agreement”), between Digital Health Acquisition Corp., a Delaware corporation (the “Company”), and [N
April 18, 2024	EX-2.1	Second Amendment to the Third Amended and Restated Business Combination Agreement, dated as of April 17, 2024, by and among Digital Health Acquisition Corp., DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., and iDoc Virtual Telehealth Solutions, Inc. (incorporated by reference to Exhibit 2.1 filed with the Form 8-K filed by the Registrant on April 18, 2024). Exhibit 2.1 DIGITAL HEALTH ACQUISITION CORP. Second AMENDMENT AND WAIVER This Second Amendment and Waiver (this “Second Amendment”) is made effective as of April 17, 2024 (the “Effective Date”), by and among Digital Health Acquisition Corp., a Delaware corporation (the “Company”), DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., and iDoc Virtual Telehealth Solutions, Inc. (each,
April 18, 2024	8-K	United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 17, 2024 Digital Health Acq United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 17, 2024 Digital Health Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Co
April 12, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001 - 41015 DIGITAL HEA
April 12, 2024	EX-97.1	Clawback Policy Exhibit 97.1 DIGITAL HEALTH ACQUISITION CORP. CLAWBACK POLICY Introduction In accordance with the applicable rules of and the listing standards of the national securities exchange on which the Company's securities are listed, Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Rule 10D-1 of the Exchange Act (“Rule 10D-1”), the Board of Directors (the “Board”) of
April 12, 2024	EX-4.5	Description of Securities. Exhibit 4.5 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2023, the end of the period covered by this Annual Report on Form 10-K, Digital Health Acquisition Corp. (the “Company,” “we,” “us,” or “our”) had three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (th
March 29, 2024	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 001-41015 CUSIP NUMBER: 253893101 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
February 27, 2024	LETTER	LETTER United States securities and exchange commission logo February 27, 2024 Scott Wolf Chief Executive Officer Digital Health Acquisition Corp.
February 14, 2024	SC 13G	DHAC / Digital Health Acquisition Corp. / Ayrton Capital LLC Passive Investment SC 13G 1 formsc13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 0)* DIGITAL HEALTH ACQUISITION CORP. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 253893101 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate
February 13, 2024	EX-10.1	Form of Amended and Restated Conversion Securities Purchase Agreement with the Bridge Investor for Shares of Common Stock in Digital Health Acquisition Corp. (incorporated by reference to Exhibit 10.1 filed with the Form 8-K filed by the Registrant on February 13, 2024). Exhibit 10.1 amended and restated SECURITIES PURCHASE AGREEMENT This AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 13, 2024, is by and among [iDoc Virtual Telehealth Solutions, Inc., a Texas corporation (“iDoc”),/VSee Lab, Inc., a Delaware corporation (“VSee”)], Digital Health Acquisition Corp, a Delaware corporation (the “Company”), and [INVESTOR], a C
February 13, 2024	EX-FILING FEES	SEC Filing Fee Table Exhibit 107 Calculation of Filing Fee Tables Form S-4 (Form Type) Digital Health Acquisition Corp.
February 13, 2024	CORRESP	Manatt, Phelps & Phillips, LLP 695 Town Center Drive, 14th Floor, Costa Mesa, California 92626 Tel: 714.371.2500 Fax: 714.371.2550 Albany \| Boston \| Chicago \| Los Angeles \| New York \| Orange County \| Sacramento \| San Francisco \| Silicon Valley \| Wash Thomas J. Poletti Manatt, Phelps & Phillips, LLP Direct Dial: (714) 371-2501 [email protected] February 13, 2024 Client-Matter: 65537-032 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Julie Sherman; Jeanne Baker; Juan Grana; Katherine Bagley Re: Digital Health Acquisition Corp. Amendment No. 5 to Registration St
February 13, 2024	EX-10.2	Form of Amended and Restated Conversion Securities Purchase Agreement with Tidewater for Shares of Common Stock in Digital Health Acquisition Corp. (incorporated by reference to Exhibit 10.2 filed with the Form 8-K filed by the Registrant on February 13, 2024). Exhibit 10.2 AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT This AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 13, 2024, is by and among iDoc Virtual Telehealth Solutions, Inc., a Texas corporation (‘iDoc”), Digital Health Acquisition Corp, a Delaware corporation (the “Company”), and Tidewater Ventures, LLC (“Tidewater”, together with iDoc and the C
February 13, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 13, 2024 Digital Health Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation)
February 13, 2024	S-4/A	As filed with the Securities and Exchange Commission on February 13, 2024 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on February 13, 2024 Registration No.
February 13, 2024	EX-10.49	Side Letter dated January 22, 2024 to the Registration Rights Agreement dated October 5, 2022 by and among Digital Health Acquisition Corp. and the Bridge Investor (incorporated by reference to Exhibit 10.49 filed with the Form S-4 filed by the Registrant on May 9, 2024). Exhibit 10.49 As of January 22, 2024 [INVESTOR] [ADDRESS] Re: Amendment to Notes and Registration Rights Agreement Dear Sirs: Reference is made to (i) the Securities Purchase Agreement dated as of October 5, 2022 (as amended by the Letter Agreement dated as of November 21, 2023 and as further amended, superseded, replaced, or otherwise modified from time to time, the “Purchase Agreement”), between
February 13, 2024	EX-2.1	First Amendment to the Third Amended and Restated Business Combination Agreement, dated as of February 13, 2024, by and among Digital Health Acquisition Corp., DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., and iDoc Virtual Telehealth Solutions, Inc. (incorporated by reference to Exhibit 2.1 filed with the Form 8-K filed by the Registrant on February 13, 2024). Exhibit 2.1 DIGITAL HEALTH ACQUISITION CORP. FIRST AMENDMENT AND WAIVER This First Amendment and Waiver (this “Amendment”) is made effective as of February 13, 2024 (the “Effective Date”), by and among Digital Health Acquisition Corp., a Delaware corporation (the “Company”), DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., and iDoc Virtual Telehealth Solutions, Inc. (each, a “Par
February 9, 2024	SC 13G/A	DHAC / Digital Health Acquisition Corp. / SPRING CREEK CAPITAL LLC - SC 13G/A Passive Investment SC 13G/A 1 d774141dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Digital Health Acquisition Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 253893101 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Stat
February 8, 2024	LETTER	LETTER United States securities and exchange commission logo February 8, 2024 Scott Wolf Chief Executive Officer Digital Health Acquisition Corp.
February 5, 2024	8-K	Other Events United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 2, 2024 Digital Health Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (
January 23, 2024	EX-10.49	Side Letter dated January 22, 2024 to the Registration Rights Agreement dated October 5, 2022 by and among Digital Health Acquisition Corp. and the Bridge Investor. Exhibit 10.49 As of January 22, 2024 [Investor] [Address] Re: Amendment to Notes and Registration Rights Agreement Dear Sirs: Reference is made to (i) the Securities Purchase Agreement dated as of October 5, 2022 (as amended by the Letter Agreement dated as of November 21, 2023 and as further amended, superseded, replaced, or otherwise modified from time to time, the “Purchase Agreement”), between
January 23, 2024	EX-FILING FEES	SEC Filing Fee Table Exhibit 107 Calculation of Filing Fee Tables Form S-4 (Form Type) Digital Health Acquisition Corp.
January 23, 2024	CORRESP	Manatt, Phelps & Phillips, LLP 695 Town Center Drive, 14th Floor, Costa Mesa, California 92626 Tel: 714.371.2500 Fax: 714.371.2550 Albany \| Boston \| Chicago \| Los Angeles \| New York \| Orange County \| Sacramento \| San Francisco \| Silicon Valley \| Wash Thomas J. Poletti Manatt, Phelps & Phillips, LLP Direct Dial: (714) 371-2501 [email protected] January 23, 2024 Client-Matter: 65537-032 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Julie Sherman; Jeanne Baker; Jordan Nimitz; Abby Adams Re: Digital Health Acquisition Corp. Amendment No. 4 to Registration Statem
January 23, 2024	S-4/A	As filed with the Securities and Exchange Commission on January 23, 2024 Table of Contents As filed with the Securities and Exchange Commission on January 23, 2024 Registration No.
December 21, 2023	PRE 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement DIGITAL HEALTH ACQUISITION CORP. (Name of Regist
November 22, 2023	EX-10.2	Second Amendment to Leak-Out Agreement, dated November 21, 2023, by and between DHAC and certain stockholders of VSee Lab, Inc. (incorporated by reference to Exhibit 10.2 filed with the Form 8-K filed by the Registrant on November 21, 2023). Exhibit 10.2 SECOND AMENDMENT TO LEAK-OUT AGREEMENT This SECOND AMENDMENT TO LEAK-OUT AGREEMENT, dated November 21, 2023 (this “Amendment”) is entered into by and between DIGITAL HEALTH ACQUISITION CORP., a Delaware corporation (the “Company”) and SALESFORCE, INC. (the “Holder”). Capitalized terms used herein, unless otherwise defined, shall have the meanings set forth in the Leak-Out Agreement, d
November 22, 2023	EX-10.12	Convertible Note Purchase Agreement, dated as of November 21, 2023, by and between Digital Health Acquisition Corp., and the Quantum Investor (incorporated by reference to Exhibit 10.12 filed with the Form 8-K filed by the Registrant on November 21, 2023). Exhibit 10.12 CONVERTIBLE NOTE PURCHASE AGREEMENT THIS CONVERTIBLE Note Purchase Agreement (this “Agreement”) is made as of November 21, 2023 (the “Effective Date”) by and between Digital Health Acquisition Corp., a Delaware corporation (the “Company”), and Quantum Assets SPV LLC, a Delaware limited liability company (the ”Investor” together with the Company the “Parties”) RECITALS A. The Parties
November 22, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 21, 2023 Date of Report (Date of earliest event reported) Digital Health Acquisition Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (
November 22, 2023	EX-10.5	Form of Exchange Agreement, dated as of November 21, 2023, by and among Digital Health Acquisition Corp., VSee Lab, Inc., and iDoc Virtual Telehealth Solutions, Inc., and the Bridge Investor (incorporated by reference to Exhibit 10.5 filed with the Form 8-K filed by the Registrant on November 21, 2023). Exhibit 10.5 EXECUTION COPY EXCHANGE AGREEMENT This Exchange Agreement (this “Agreement”) is dated as of November 21, 2023, between Digital Health Acquisition Corp., a Delaware corporation (“DHAC”), VSee Lab, Inc., a Delaware corporation (“VSee”) and iDoc Virtual Telehealth Solutions, Inc., a Texas corporation (“iDoc”, and together with DHAC and VSee, each a “Company” and collectively, the “Compan
November 22, 2023	EX-10.10	Form of Conversion Securities Purchase Agreement for Shares of Series A Preferred Stock in Digital Health Acquisition Corp. (incorporated by reference to Exhibit 10.10 filed with the Form 8-K filed by the Registrant on November 21, 2023). Exhibit 10.10 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 21, 2023, is by and between Digital Health Acquisition Corp, a Delaware corporation (the “Company”), and [], [] (“[]”). RECITALS A. The Company and [] are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2
November 22, 2023	EX-10.16	Form of Equity Purchase Commitment Note (incorporated by reference to Exhibit 10.16 filed with the Form 8-K filed by the Registrant on November 21, 2023). Exhibit 10.16 NONE OF THIS SECURITY OR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, NONE OF THEM MAY BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECT

DHAC / Digital Health Acquisition Corp. - SEC-Einreichungen, Jahresbericht, Proxy Statement

Basisstatistiken

SEC Filings

SEC Filings (Chronological Order)

How Much do you Like Fintel?

Write a Review and get 25% Off Your Next Purchase

How can we Improve?